Agreement with Elsevier extended until 2020
In late 2018, when the ‘current’ contract with Elsevier ended, VSNU and Elsevier agreed to continue the talks on a new contract while the existing agreements were maintained. Now the current contract will be extended for an additional six months to allow more time for the negotiations.
Researchers of Maastricht University (UM) and Maastricht University Medical Centre (MUMC+) can publish without any extra costs (APC) in almost 400 peer-reviewed Elsevier journals. Researchers and students also have access to read articles in all Elsevier journals.
During the ongoing negotiations with Elsevier, a new contract that includes access to publications and free open access publishing in more journals will be discussed. Also, the National Plan Open Science (NPOS) and the final Plan S guidance will be part of the negotiation.
Source: UM Library
Also read:
-
Recognition & Rewards is rector Rianne Letschert’s top priority
Thursday, June 11, 2020Read moreRecognition & Rewards represents no less than a fundamental shift in the Dutch academic world. The programme has come about partly through the spirited advocacy of the youngest rector magnificus in the country.
-
Dutch research institutions and Elsevier agreed on a new extensive agreement
Wednesday, May 20, 2020Read moreThe Association of Universities in the Netherlands (VSNU), the Dutch Federation of University Medical Centers (NFU), the Netherlands Organization for Scientific Research (NWO) and Elsevier announced that they have entered into a national agreement. Maastricht University and MUMC+ participate in this contract that runs until 2025.
-
Dutch research institutions and Elsevier reach framework agreement
Thursday, December 19, 2019Read moreVSNU, NFU, NWO and Elsevier have reached a framework agreement. In the short term, this means that from January 2020 we will have access to all online journals from Elsevier and UM scholars can publish Open Access in all Elsevier journals – Full OA and Hybrid – without paying APC.
Facebook
Twitter
LinkedIn
Forward
Reddit